期刊文献+

高效液相色谱法测定注射用培美曲塞二钠的含量 被引量:1

下载PDF
导出
摘要 目的建立高效液相色谱法测定注射用培美曲塞二钠含量。方法以十八烷基硅烷键合硅胶为填充剂;以0.02mol·L-1磷酸钠溶液(用磷酸调节pH至4.0)-乙腈(86∶14)为流动相,检测波长240nm。结果进样量在0.4~4.2μg范围内与峰面积的线性关系良好(r=0.9999),回收率为99.80%(n=9),RSD=0.24%。结论该法简便、快速、准确,专属性强,可作为注射用培美曲塞二钠的含量测定方法。
作者 贾佳 刘冬
出处 《医药导报》 CAS 2010年第8期1086-1087,共2页 Herald of Medicine
  • 相关文献

参考文献3

二级参考文献45

  • 1[1]HANAUSKE AR,CHEN V,PAOLETTI P,et al.Pemetrexed disodium:a novel antifolate clinically active against multiple solid tumors [J].Oncologist,2001,6(4):363-373.
  • 2[2]ADJEI AA.Pemetrexed:a multitargeted antifolate agent with promising activity in solid tumors [J].Ann Oncol,2000,11(10):1335-1341.
  • 3[3]SCHULTZ RM,PATEL VF,WORZALLA JF,et al.Role of thymidylate synthase in the antitumor activity of the multitargeted antifolate,LY231514 [J].Anticancer Res,1999,19(1A):437-443.
  • 4[4]TEICHER BA,CHEN V,SHIH C,et al.Treatment regimens including the multitargeted antifolate LY231514 in human tumor xenografts.[J].Clin Cancer Res,2000,6(3):1016-1023.
  • 5[5]FOSSELLA FV,GATZEMEIER U.Phase I trials of pemetrexed [J].Semin Oncol,2002,29(2 Suppl 5):8-16.
  • 6[6]RINALDI DA,KUHN JG,BURRIS HA,et al.A phase I evaluation of multitargeted antifolate (MTA,LY231514),administered every 21 days,utilizing the modified continual reassessment method for dose escalation [J].Cancer Chemother Pharmacol,1999,44(5):372-380.
  • 7[7]THODTMANN R,DEPENBROCK H,DUMEZ,et al.Clinical and pharmacokinetic phase I study of multitargeted antifolate (LY231514) in combination with cisplatin [J].J Clin Oncol,1999,17(10):3009-3016.
  • 8[8]HUGHES A,CALVERT P,AZZABI A,et al.Phase I Clinical and Pharmacokinetic Study of Pemetrexed and Carboplatin in Patients With Malignant Pleural Mesothelioma [J].J Clin Oncol,2002,20(16):3533-3544.
  • 9[9]RUSTHOVEN JJ,EISENHAUER E,BUTTS C,et al.Targeted antifolate LY231514 as first-line chemotherapy for patients with advanced non-small-cell lung cancer:a phase II study.National Cancer Institute of Canada Clinical Trials Group [J].J Clin Oncol,1999 ,17(4):1194.
  • 10[10]CLARKE SJ,ABRATT R,GOEDHALS L,et al.Phase II trial of pemetrexed disodium (ALIMTA,LY231514) in chemotherapy-naive patients with advanced non-small-cell lung cancer [J].Ann Oncol,2002,13(5):737-741.

共引文献70

同被引文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部